+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Fermenters Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 143 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5912161
The global fermenters market size reached US$ 1.6 Billion in 2022. Looking forward, the market is expected to reach US$ 2.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2022-2028.

Fermenters, also known as stirred-tank bioreactors, are small, economical, sterilized process vessels used to cultivate heterotrophic microalgae. They use probes, sensors, and controlled clean-in-place systems to monitor conditions and maintain optimal levels of microbial growth. At present, they are utilized to manufacture a broad range of products, such as vinegar, cellulose, ethanol, protease, lipase, amylase, streptomycin, citric acid, lactic acid, and glutamic acid. These products find extensive applications in the pulp and paper production, biological wastewater treatment, and industrial solvents worldwide.

Fermenters Market Trends

Fermenters can produce large yields quickly, tolerate unusual growth conditions like acidic or high temperatures and be genetically modified. As a result, they are widely utilized in the pharmaceutical industry to produce a wide range of chemical compounds, enzymes, and drugs. The escalating demand for these drugs on account of the rising prevalence of infectious and chronic diseases represents one of the major factors influencing the market positively. Apart from this, the fermentation process destroys harmful microorganisms and chemicals and adds beneficial bacteria that aids in digestion. As a result, fermenters are finding applications in the food and beverage (F&B) industry to preserve and alter the texture of soy products, dairy items, grains, and vegetables. Moreover, the increasing awareness among individuals about the health benefits of consuming fermented food products, which include improving the intestinal tract, immune system, and bioavailability of nutrients, and reducing the chances of lactose intolerance, allergy, and cancers, is contributing to market growth. Furthermore, fermenters can be incorporated with advanced technologies to facilitate process monitoring, data acquisition and storage, error detection, filtering, unit conversion, and measurement calculations, which is impelling the market growth.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global fermenters market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on process, mode of operation, material and end user.

Breakup by Process:

  • Batch
  • Fed-Batch
  • Continuous

Breakup by Mode of Operation:

  • Semi-Automatic
  • Automatic

Breakup by Material:

  • Stainless-Steel
  • Glass

Breakup by End User:

  • Food and Beverages
  • Pharmaceutical
  • Personal Care

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Applikon Biotechnology B.V. (Getinge AB), bbi-biotech GmbH, Bioengineering AG, CerCell A/S, Electrolab Biotech Ltd, GEA Group Aktiengesellschaft, General Electric Company, Pierre Guérin SAS (ENGIE Group Company), Sartorius AG, Thermo Fisher Scientific Inc. and ZETA Holding GmbH.

Key Questions Answered in This Report:

  • How has the global fermenters market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global fermenters market?
  • What are the key regional markets?
  • What is the breakup of the market based on the process?
  • What is the breakup of the market based on the mode of operation?
  • What is the breakup of the market based on the material?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global fermenters market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Fermenters Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Process
6.1 Batch
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Fed-Batch
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Continuous
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Mode of Operation
7.1 Semi-Automatic
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Automatic
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Material
8.1 Stainless-Steel
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Glass
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Food and Beverages
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Pharmaceutical
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Personal Care
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Applikon Biotechnology B.V. (Getinge AB)
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 bbi-biotech GmbH
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Bioengineering AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 CerCell A/S
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Electrolab Biotech Ltd
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 GEA Group Aktiengesellschaft
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 General Electric Company
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Pierre Guérin SAS (ENGIE Group Company)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Sartorius AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Thermo Fisher Scientific Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 ZETA Holding GmbH
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio

Companies Mentioned

  • Applikon Biotechnology B.V. (Getinge AB)
  • bbi-biotech GmbH
  • Bioengineering AG
  • CerCell A/S
  • Electrolab Biotech Ltd
  • GEA Group Aktiengesellschaft
  • General Electric Company
  • Pierre Guérin SAS (ENGIE Group Company)
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • ZETA Holding GmbH

Methodology

Loading
LOADING...

Table Information